微创入路不损害全肺切除术预后:基于美国国家癌症数据库的比较
该研究利用美国国家癌症数据库2010–2014年4938例非小细胞肺癌全肺切除术病例,比较微创与开胸入路的围手术期死亡和总生存。结果显示两组30天和90天死亡率无差异,微创组淋巴结检出数更高,但校正后总生存获益不显著。
要点
- 微创全肺切除术30天和90天死亡率与开胸相当
- 微创组淋巴结检出数高于开胸组
- 微创组中转开胸率为36.7%
核心结论
- 微创入路行全肺切除术不增加围手术期死亡率,也不损害长期生存。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库2010–2014年因非小细胞肺癌行全肺切除术的患者,按意向治疗分析比较微创与开胸。
主要发现
- 共4938例患者接受全肺切除术,其中755例(15.3%)通过微创完成。
- 微创组与开胸组30天死亡率分别为6.8%和6.7%(p=0.9),90天死亡率分别为12.3%和11.9%(p=0.86)。
- 微创组平均淋巴结检出数为17.1±0.4枚,开胸组为16.1±0.2枚(p=0.034)。
- 微创组中转开胸率为36.7%。
- 单因素分析中微创与总生存改善相关,但多因素分析中该关联不显著。
临床怎么用
- 对于适合全肺切除术的非小细胞肺癌患者,微创入路可作为不损害围手术期安全和长期预后的可选方式。
局限性
- 原文未明确列出局限性,需注意其为回顾性数据库研究且微创组样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Minimally invasive approaches are increasingly being used for the conduct of complex surgical procedures. Whether the benefits of minimally invasive approaches compared to thoracotomy for sublobar and lobar lung resection for NSCLC are realized for patients undergoing pneumonectomy is not clear. METHODS: The National Cancer Database was queried for patients who underwent pneumonectomy for NSCLC from 2010 to 2014. Case data from patients who underwent resection by minimally invasive surgery (MIS) were compared with those from patients who received thoracotomy (open) in an intention-to-treat analysis. Associations between potential covariates and treatment were analyzed using the Pearson chi-square test for categorical variables and Wilcoxon rank sum test for continuous variables. Univariable and multivariable logistic models and proportional hazards model were used to assess the effect of surgical approach on 30-day and 90-day mortality and overall survival. Relative prognosis was summarized using odds ratios and hazards ratios estimates and 95% confidence limits. RESULTS: A total of 4,938 patients underwent pneumonectomy during the study period, of which 755 (15.3%) were completed by MIS. No difference was noted in 30- and 90-day mortality rates for MIS compared to open approaches (6.8% and 12.3% versus 6.7% and 11.9%, respectively; p = 0.9 and 0.86, respectively). Tumor histology and stage characteristics were similar between the two groups. The mean number of lymph nodes examined was higher in the MIS group compared to the open thoracotomy group (17.1 ± 0.4 versus 16.1 ± 0.2, p = 0.034). The conversion rate for the MIS cohort was 36.7%. Surgical approach was not associated with any difference in perioperative mortality with univariable or multivariable analysis. MIS was associated with improved overall survival on univariable analysis, but this was not evident with multivariable analysis. CONCLUSIONS: Pneumonectomy performed by minimally invasive approaches does not compromise perioperative mortality or long-term outcomes. Further investigation into the impact of minimally invasive approaches on perioperative outcomes for whole-lung resection is warranted.
引用
- Hennon MW, Kumar A, Devisetty H, et al. Minimally Invasive Approaches Do Not Compromise Outcomes for Pneumonectomy: A Comparison Using the National Cancer Database. J Thorac Oncol. 2018. PMID: 30292851. doi:10.1016/j.jtho.2018.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。